Oct 17 (Reuters) - Aequus Pharmaceuticals Inc AQS.V
* Aequus advances clinical development of Transdermal Aripiprazole Patch
* Upon approval of CTA, Co plans to initiate repeat dose, 28-day safety, study of Aripiprazole Transdermal Patches in late 2016 Source text for Eikon: ID:nMKWgtLxRa Further company coverage: AQS.V